BeOne Medicines: Redefining Cancer Care

Jan 12, 2026

BeOne Medicines Co-Founder, Chairman and CEO John V. Oyler shares how the company is challenging the status quo in oncology, with a focus on affordability and access to benefit patients everywhere.

Insights

WATCH: John V. Oyler on BeOne Medicine Transforming Cancer Care

In this episode of Exceptional Leaders / Exceptional Ideas, Morgan Stanley’s Sean Laaman sits down with BeOne Medicines Co-Founder, Chairman and CEO John V. Oyler to explore how in‑house trials, global partnerships and a commitment to affordability are transforming oncology for patients everywhere. 

More Exceptional Leaders

Watch other episodes in this series from Morgan Stanley Research, as the firm’s equity analysts sit down with business leaders at world-class global companies to unpack broad foundational changes in sectors, industries and markets.

More Insights